Thermo Fisher to Expand its Clinical Trials Capabilities and Collaborates with Frontier to Develop Therapy for HIV
Shots:
- Thermo Fisher expands its clinical trials supply and distribution services network in China with the investment of $4.4M in its Suzhou facility to support the growth of clinical studies and to provide biotech companies with the resources to develop and commercialize new therapies in China
- Additionally- Thermo Fisher collaborates with Frontier to expedite the commercialization of 3BNC117 and will be the exclusive manufacturing partner of 3BNC117 to support pivotal study- PPQ & global commercial supply by manufacturing it in its St. Louis facility
- The new clinical trial facility adds 10°C-20°C beta-lactam storage- cold chain capacity- and increases current storage capacity for temperatures at 15°C to 25°C- 2°C to 8°C and -20°C making it Thermo Fisher’s largest clinical trial facility in Suzhou
Click here to read full press release/ article | Ref: Thermo Fisher | Image: BioTecNika
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com